Sofinnova’s 50-Year Legacy: Accelerating Biotech Innovation with NVIDIA AI

Post Content

​ Meet Simon Turner, partner at Sofinnova—one of the world’s oldest life sciences funds, driving global impact in biotech, industrial biotech, medical devices, and digital medicine.

See how Sofinnova’s collaboration with NVIDIA’s VC Alliance lets them streamline analysis, speed results, and supercharge innovation for 100+ portfolio companies.

Learn more about how NVIDIA accelerates portfolio innovation: https://nvda.ws/46ob7Kk   Read More NVIDIA 

#Techno #nvidia